Thinking post-Paxlovid: Rutgers researchers eye the next generation of COVID drugs
Gothamist is a non-profit local newsroom, powered by WNYC.
Source: gothamist.com
Stay updated with breaking news from Jun Wang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gothamist is a non-profit local newsroom, powered by WNYC.
(CTN News) - Rutgers University researchers have significantly advanced in developing a novel oral treatment for COVID-19, which could provide an alternative
SARS-CoV-2 eventually will become resistant to the only effective oral treatment Paxlovid, scientists say. The world needs another.
NASA’s TEMPO listed in Time magazine’s best inventions of 2023
Trial of third defendant in Bagley death set for January (click for more)